At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 186 enrolled
Drug / intervention
ASC-J9 cream +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled Dose-Ranging Clinical Study to Evaluate the Safety and Efficacy of ASC-J9 Cream Applied Twice Daily for 12 Weeks for the Treatment of Facial Acne Vulgaris
In Brief
A Phase 2 clinical trial evaluating ASC-J9 cream and placebo for Acne Vulgaris. Completed, enrolled 186 participants across 10 sites.
Detailed Summary
The purpose of this study is to evaluate if topical ASC-J9 cream is effective in treating acne.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2007
First PostedSep 2007
Primary CompletionApr 2008
Study CompletionJul 2008
TodayJul 2026
First PostedSep 5, 2007
Enrollment StartAug 1, 2007
Primary CompletionApr 1, 2008
Study CompletionJul 1, 2008
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 18.8 years ago
Interventions
ASC-J9 creamdrug
Topical application to the face twice daily for 12 weeks.
placebodrug
vehicle control applied topically twice daily for 12 weeks